Chlamydia trachomatis antibody detection and diagnosis of reactive arthritis

British Journal of Rheumatology

Volumn 37, Issue 10, 1998, Pages 1054-1059

  Bas, S ^a   Vischer, T L ^a  

^a UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Antibodies; Chlamydia trachomatis; Enzyme linked immunoassay; Sexually acquired reactive arthritis; Synovial fluid

Indexed keywords

ANTIBODY; ANTIGEN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; SYNTHETIC PEPTIDE;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ARTHROPATHY; ARTICLE; CHLAMYDIA TRACHOMATIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; INFLAMMATORY DISEASE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REACTIVE ARTHRITIS; RHEUMATOLOGY; SEXUALLY TRANSMITTED DISEASE; SYNOVIAL FLUID LEVEL;

ADOLESCENT; ADULT; AGED; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; ARTHRITIS, REACTIVE; BACTERIAL OUTER MEMBRANE PROTEINS; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EVALUATION STUDIES; FEMALE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; PORINS; PREDICTIVE VALUE OF TESTS; RECOMBINANT PROTEINS; SYNOVIAL FLUID;

EID: 0031757135     PISSN: 02637103     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Weyand CM, Goronzy JJ. Clinically silent infections in patients with oligoarthritis: results of a prospective study. Ann Rheum Dis 1992;51:253-8.
2. Kvien TK, Glennås A, Melby K et al. Reactive arthritis: incidence, triggering agents and clinical presentation. J Rheumatol 1994;21:115-22.
3. Wollenhaupt HJ, Kolbus F, Weissbrodt H et al. Manifestations of Chlamydia induced arthritis in patients with silent versus symptomatic urogenital chlamydial infection. Clin Exp Rheumatol 1995;13:453-8.
4. Bas S, Cunningham T, Kvien TK, Glennås A, Melby K, Vischer TL. The value of isotype determination of serum antibodies against Chlamydia for the diagnosis of Chlamydia reactive arthritis. Br J Rheumatol 1996; 35:542-7.
5. Karvonen M, Tuomilehto J, Pitkäniemi J, Naukkarinen A, Saikku P. Chlamydia pneumoniae IgG antibody prevalence in south-western and eastern Finland in 1982 and 1987. Int J Epidemiol 1994;23:176-84.
6. Kuo CC, Jackson LA, Campbell LA, Grayston JT. Chlamydia pneumoniae (TWAR). Clin Microbiol Rev 1995;8:451-61.
7. Schachter J. Chlamydial infections. N Engl J Med 1978;298:428-35.
8. Meijer CJ, Calame JJ, de Windt EJ et al. Prevalence of Chlamydia trachomatis infection in a population of asymptomatic women in a screening program for cervical cancer. Eur J Clin Microbiol Infect Dis 1989;8:127-30.
9. Hammerschlag MR, Chirgwin K, Roblin PM et al. Persistent infection with Chlamydia pneumoniae following acute respiratory illness. Clin Infect Dis 1992;14: 178-82.
10. Bas S, Griffais R, Kvien TK, Glennås A, Melby K, Vischer TL. Amplification of plasmid and chromosome Chlamydia DNA in synovial fluid of patients with reactive arthritis and undifferentiated seronegative oligoarthropathies. Arthritis Rheum 1995;38:1005-13.
11. Beatty WL, Byrne GI, Morrison RP. Morphologic and antigenic characterization of interferon γ-mediated persistent Chlamydia trachomatis infection in vitro. Proc Natl Acad Sci USA 1993;90:3998-4002.
12. Beatty WL, Morrison RP, Byrne GI. Persistent chlamydiae: from cell culture to a paradigm for Chlamydia pathogenesis. Microbiol Rev 1994;58:686-99.
13. Beatty WL, Morrison RP, Byrne GI. Immunoelectron-microscopic quantitation of differential levels of chlamydial proteins in cell culture model of persistent Chlamydia trachomatis infection. Infect Immun 1994; 62:4059-62.
14. Beatty WL, Morrison RP, Byrne GI. Reactivation of persistent Chlamydia trachomatis infection in cell culture. Infect Immun 1995;63:199-205.